Review



brat 5 [haemonetics]  (Haemonetics)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Haemonetics brat 5 [haemonetics]
    Brat 5 [Haemonetics], supplied by Haemonetics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/brat+5+%5Bhaemonetics%5D/brat5+bowl+system/10__1002_slash_14651858__cd001888__pub5-8360-116-118
    Average 90 stars, based on 1 article reviews
    brat 5 [haemonetics] - by Bioz Stars, 2026-09
    90/100 stars

    Images

    Related Articles

    Control:

    Article Title: Effects of cell-saving devices and filters on transfusion in cardiac surgery: a multicenter randomized study.
    Article Snippet: Department of Intensive Care and Thorax Centre Twente, Medisch Spectrum Twente Enschede, Enschede; Division of Anesthesiology, Intensive Care and Emergency Medicine, University Medical Centre Utrecht, Utrecht; Departments of Cardiothoracic Surgery, Anesthesiology, and Epidemiology, University Medical Centre Groningen, Groningen; Department of Anesthesiology and Pain Therapy, Maastricht University Medical Centre, Maastricht; Department of Cardiothoracic Surgery, Catharina Ziekenhuis, Eindhoven; Department of Cardiac Anesthesia, Medisch Centrum Leeuwarden, Leeuwarden; and Department of Anesthesia, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands

    Article Title: Cell salvage for minimising perioperative allogeneic blood transfusion in adults undergoing elective surgery
    Article Snippet: Cochrane Database of Systematic Reviews • MI (NR) Unsworth 1996 RCT Registration: N/ A Country: UK N = 105 Cardiothoracic (CABG) (on CPB) Timing of collection: postoperative Washing: unwashed Transfusion threshold: Hct < 25% System: NR (Cardiotomy reservoir = CATR 3500) Group 2: uncoated autotransfusion and Group 3: coated autotransfusion (combined) N = 71 Group 1: no autotransfusion N = 34 • Transfusions (NR)• Volume (NR)• Blood loss (NA)• Mortality (NR)• Re-operation (NR) Vermeijden 2015 RCT Registration: Retrospective (one year) Country: The Netherlands N = 716 Cardiothoracic (CABG, valve) (on CPB) Timing of collection: intraoperative Washing: washed Transfusion threshold: Hb < 5 mmol/L System: The centers used their own CS with standard washing program (CATS [Fresenius], Brat 5 [Haemonetics, Braintree, MA], or Dideco-electa [Sorin, Milan, Italy] Group CS & Group CS + Filter N = 364 Group Filter & Group Control N = 352 • Transfusions (inhospital)• Volume (in-hospital)• Blood loss (perioperative)• Mortality (1 year)• Infection (discharge)• MI (NR)• CVA/stroke (NR)• Hospital LOS Ward 1993 RCT Registration: N/ A Country: USA N = 35 Cardiothoracic (CABG, valve) Timing of collection: postoperative Washing: unwashed Transfusion threshold: Hb < 8 g/dL System: In-line autotransfusion system (Gish Biomedical, Inc, Santa Ana, CA) Autotransfusion N = 18 Control (no autotransfusion) N = 17 • Transfusions (NR)• Volume (NA)• Blood loss (NR)• Mortality (NR)• Re-operation (NR)• Infection (NR)• Wound complication (NR)• MI (NR) Westerberg 2004 RCT Registration: N/ A Country: Sweden N = 29 Cardiothoracic (CABG) (on CPB) Timing of collection: both intra and postoperatively Washing: NR Transfusion threshold: No protocol System: D 903 Avant, Dideco; Mirandola, Modena, Italy) Retransfusion Group N = 12 No-Retransfusion Group N = 17 • Transfusions (NR)• Blood loss (12 hours ) Xie 2015 RCT Registration: Prospective Country: China N = 150 Cardiothoracic (on CPB) Timing of collection: intraoperative Washing: washed Transfusion threshold: Hb < 80 g/L System: Haemonetics, USA, volume of disposable centrifuge bowl is 125mL Group CS (cell salvage) N = 75 Group C (control) N = 75 • Transfusions (24 hours)• Volume (NR)• Blood loss (intraoperative)• Mortality (24 hours)• Hospital LOS Zhao 2003 RCT Registration: N/ A Country: China N = 60 Cardiothoracic (CABG) (on CPB) Timing of collection: postoperative Washing: unwashed Transfusion threshold: No protocol Group 1: shed mediastinal blood N = 30 Group 2: banked blood only N = 30 • Transfusions (NR)• Volume (NR)• Blood loss (NA) Table 6.

    Article Title: The influence of homologous blood transfusion on immunity and clinical outcome in aortic surgery.
    Article Snippet: Allocation was stratified using rifugal devices (Cell saver 5, Haemonetics, U.K. or Brat 2, Cobe Laboratories, U.K.).

    Infection:

    Article Title: Effects of cell-saving devices and filters on transfusion in cardiac surgery: a multicenter randomized study.
    Article Snippet: Department of Intensive Care and Thorax Centre Twente, Medisch Spectrum Twente Enschede, Enschede; Division of Anesthesiology, Intensive Care and Emergency Medicine, University Medical Centre Utrecht, Utrecht; Departments of Cardiothoracic Surgery, Anesthesiology, and Epidemiology, University Medical Centre Groningen, Groningen; Department of Anesthesiology and Pain Therapy, Maastricht University Medical Centre, Maastricht; Department of Cardiothoracic Surgery, Catharina Ziekenhuis, Eindhoven; Department of Cardiac Anesthesia, Medisch Centrum Leeuwarden, Leeuwarden; and Department of Anesthesia, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands

    Article Title: Cell salvage for minimising perioperative allogeneic blood transfusion in adults undergoing elective surgery
    Article Snippet: Cochrane Database of Systematic Reviews • MI (NR) Unsworth 1996 RCT Registration: N/ A Country: UK N = 105 Cardiothoracic (CABG) (on CPB) Timing of collection: postoperative Washing: unwashed Transfusion threshold: Hct < 25% System: NR (Cardiotomy reservoir = CATR 3500) Group 2: uncoated autotransfusion and Group 3: coated autotransfusion (combined) N = 71 Group 1: no autotransfusion N = 34 • Transfusions (NR)• Volume (NR)• Blood loss (NA)• Mortality (NR)• Re-operation (NR) Vermeijden 2015 RCT Registration: Retrospective (one year) Country: The Netherlands N = 716 Cardiothoracic (CABG, valve) (on CPB) Timing of collection: intraoperative Washing: washed Transfusion threshold: Hb < 5 mmol/L System: The centers used their own CS with standard washing program (CATS [Fresenius], Brat 5 [Haemonetics, Braintree, MA], or Dideco-electa [Sorin, Milan, Italy] Group CS & Group CS + Filter N = 364 Group Filter & Group Control N = 352 • Transfusions (inhospital)• Volume (in-hospital)• Blood loss (perioperative)• Mortality (1 year)• Infection (discharge)• MI (NR)• CVA/stroke (NR)• Hospital LOS Ward 1993 RCT Registration: N/ A Country: USA N = 35 Cardiothoracic (CABG, valve) Timing of collection: postoperative Washing: unwashed Transfusion threshold: Hb < 8 g/dL System: In-line autotransfusion system (Gish Biomedical, Inc, Santa Ana, CA) Autotransfusion N = 18 Control (no autotransfusion) N = 17 • Transfusions (NR)• Volume (NA)• Blood loss (NR)• Mortality (NR)• Re-operation (NR)• Infection (NR)• Wound complication (NR)• MI (NR) Westerberg 2004 RCT Registration: N/ A Country: Sweden N = 29 Cardiothoracic (CABG) (on CPB) Timing of collection: both intra and postoperatively Washing: NR Transfusion threshold: No protocol System: D 903 Avant, Dideco; Mirandola, Modena, Italy) Retransfusion Group N = 12 No-Retransfusion Group N = 17 • Transfusions (NR)• Blood loss (12 hours ) Xie 2015 RCT Registration: Prospective Country: China N = 150 Cardiothoracic (on CPB) Timing of collection: intraoperative Washing: washed Transfusion threshold: Hb < 80 g/L System: Haemonetics, USA, volume of disposable centrifuge bowl is 125mL Group CS (cell salvage) N = 75 Group C (control) N = 75 • Transfusions (24 hours)• Volume (NR)• Blood loss (intraoperative)• Mortality (24 hours)• Hospital LOS Zhao 2003 RCT Registration: N/ A Country: China N = 60 Cardiothoracic (CABG) (on CPB) Timing of collection: postoperative Washing: unwashed Transfusion threshold: No protocol Group 1: shed mediastinal blood N = 30 Group 2: banked blood only N = 30 • Transfusions (NR)• Volume (NR)• Blood loss (NA) Table 6.

    Article Title: The influence of homologous blood transfusion on immunity and clinical outcome in aortic surgery.
    Article Snippet: Allocation was stratified using rifugal devices (Cell saver 5, Haemonetics, U.K. or Brat 2, Cobe Laboratories, U.K.).



    Similar Products

    brat 5 [haemonetics]  (Haemonetics)
    90
    Haemonetics brat 5 [haemonetics]
    Brat 5 [Haemonetics], supplied by Haemonetics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/brat+5+%5Bhaemonetics%5D/brat5+bowl+system/10__1002_slash_14651858__cd001888__pub5-8360-116-118
    Average 90 stars, based on 1 article reviews
    brat 5 [haemonetics] - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results